Repurposing Clemastine to Target Glioblastoma Cell Stemness
Michael A. Sun(Duke Medical Center), Yiping He(Dalian University of Technology)
Cited by 4
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
MTAP loss correlates with an immunosuppressive profile in GBM and its substrate MTA stimulates alternative macrophage polarization
|Scientific Reports|2022|33
Mutant allele quantification reveals a genetic basis for TP53 mutation-driven castration resistance in prostate cancer cells
|Scientific Reports|2018|6
Distribution and vulnerability of transcriptional outputs across the genome in Myc-amplified medulloblastoma cells
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1